Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/05/311
Active ingredient: Troxacitabine
Indication: Treatment of acute myeloid leukaemia
Sponsor: Pharm Research Associates (UK) Limited
Pacific House, Imperial Way, Reading, Berkshire RG2 0TD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/09/2005 Orphan designation EMEA/OD/045/05 (2005)3318 of 26/08/2005
22/03/2007 Transfer of orphan designation EMEA/OD/045/05/T/01 (2007)1319 of 20/03/2007
14/01/2008 Removal of orphan designation from Community Register